VST insider Form 4: CEO executes 10b5‑1 plan with sales and gift
Rhea-AI Filing Summary
Vistra Corp. (VST) reported insider transactions by its President & CEO and Director, executed under a Rule 10b5-1 trading plan adopted on June 12, 2025. Between October 10–14, 2025, the reporting person exercised employee stock options at $14.03 and $19.68 per share and sold shares in multiple trades.
Examples include sales of 19,200 shares at $209.76, 2,164 shares at $208.50, 39,437 shares at $201.12, and 1,989 shares at $205.29, plus a sale of 2,170 shares at a $204.74 weighted-average price (range $204.15–$205.12). A 27,893-share gift was also reported. Following these transactions, direct beneficial ownership stood at 277,315 shares, with additional indirect holdings of 701,514 shares (JAMEB, LP), 34,000 shares (James A. Burke 2012 Trust), and 259 shares (Marti E. Burke 2012 Trust).
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | 2016 Employee Stock Option (right to buy) | 28,163 | $0.00 | -- |
| Exercise | 2018 Employee Stock Option (right to buy) | 24,000 | $0.00 | -- |
| Exercise | Common Stock | 28,163 | $14.03 | $395K |
| Exercise | Common Stock | 24,000 | $19.68 | $472K |
| Sale | Common Stock | 19,200 | $205.68 | $3.95M |
| Sale | Common Stock | 2,170 | $204.74 | $444K |
| Exercise | 2016 Employee Stock Option (right to buy) | 21,837 | $0.00 | -- |
| Exercise | 2018 Employee Stock Option (right to buy) | 22,000 | $0.00 | -- |
| Exercise | Common Stock | 21,837 | $14.03 | $306K |
| Exercise | Common Stock | 22,000 | $19.68 | $433K |
| Gift | Common Stock | 27,893 | $0.00 | -- |
| Sale | Common Stock | 39,437 | $201.12 | $7.93M |
| Sale | Common Stock | 1,989 | $205.29 | $408K |
| Exercise | 2018 Employee Stock Option (right to buy) | 24,000 | $0.00 | -- |
| Exercise | Common Stock | 24,000 | $19.68 | $472K |
| Sale | Common Stock | 19,200 | $209.76 | $4.03M |
| Sale | Common Stock | 2,164 | $208.50 | $451K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025. Includes an aggregate of approximately (i) 1,807 shares sold for the cashless exercise of the stock options; and (ii) 6,847 shares sold to pay taxes in connection with the exercise of the stock options. Includes an aggregate of approximately (i) 452 shares sold for the cashless exercise of the stock options; and (ii) 1,712 shares sold to pay taxes in connection with the exercise of the stock options. Includes an aggregate of approximately (i) 5,179 shares sold for the cashless exercise of the stock options; and (ii) 24,569 shares sold to pay taxes in connection with the exercise of the stock options. Includes an aggregate of approximately (i) 423 shares sold for the cashless exercise of the stock options; and (ii) 1,989 shares sold to pay taxes in connection with the exercise of the stock options. Includes an aggregate of approximately (i) 1,843 shares sold for the cashless exercise of the stock options; and (ii) 6,833 shares sold to pay taxes in connection with the exercise of the stock options. Includes an aggregate of approximately (i) 462 shares sold for the cashless exercise of the stock options; and (ii) 1,708 shares sold to pay taxes in connection with the exercise of the stock options. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.15 to $205.12, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Options vested 50% 4 years from the grant date with the remaining 50% vesting 5 years from the grant date. Options vested in four equal annual installments beginning October 3, 2017.